Showing 1921-1930 of 2494 results for "".
- Eyenovia Announces Promotion of Bren Kern to Chief Operating Officer and Corporate Vice Presidenthttps://modernod.com/news/eyenovia-announces-promotion-of-bren-kern-to-chief-operating-officer-and-corporate-vice-president/2481283/Eyenovia announced that Bren Kern, who currently serves as Eyenovia’s Senior Vice President of Manufacturing and Operations, has been promoted to Chief Operating Officer and Corporate Vice President, effective January 1. “Since joining the company earlier this year, Bren has
- Atsena Therapeutics Expands Leadership Team with Appointment of Lis Leiderman, MD, MBA, as Chief Financial Officer and Chief Business Officerhttps://modernod.com/news/atsena-therapeutics-expands-leadership-team-with-appointment-of-lis-leiderman-md-mba-as-chief-financial-officer-and-chief-business-officer/2481229/Atsena Therapeutics announced the appointment of Elisabeth (Lis) Leiderman, MD, MBA, as Chief Financial Officer and Chief Business Officer. Dr. Leiderman has more than 15 years of finance, business development and strategy experience in the life sciences industry, most recently with gene the
- In Final Rule, CMS Rejects Proposal to Make Facility Payments for Office-Based Ophthalmic Surgerieshttps://modernod.com/news/in-final-rule-cms-rejects-proposal-to-make-facility-payments-for-office-based-ophthalmic-surgeries/2481218/In its Medicare Physician Fee Schedule Final Rule for 2023, CMS rejected a proposal to make facility payments for office-based ophthalmic surgeries. The following is a summary of this and other key points in the ruling. Office-based payments. In response to requests to
- CooperVision MiSight 1 Day Officially Launches in Chinahttps://modernod.com/news/coopervision-misight-1-day-officially-launches-in-china/2481026/CooperVision and EssilorLuxottica have officially launched MiSight 1 day contact lenses in China, marking its availability in the world’s largest country for myopia management. It is the first product of any type that has an indication from the Chinese National Medical Products Adminis
- Atsena Therapeutics Announces Opening of New Office and Laboratory Space in North Carolina’s Research Trianglehttps://modernod.com/news/atsena-therapeutics-announces-opening-of-new-office-and-laboratory-space-in-north-carolinas-research-triangle/2480994/Atsena Therapeutics announced the opening of its new office and laboratory in the Alexandria Center for Advanced Technologies–Research Triangle. The occasion was celebrated during a ribbon-cutting ceremony yesterday. The new state-of-the-art facility consist
- Euclid Vision Announces Official Launch of Cloud-Based Portalhttps://modernod.com/news/euclid-vision-announces-official-launch-of-cloud-based-portal/2480964/Euclid Vision has announced the official rollout of MyEuclid, an interactive, web-based customer portal designed to drive practice efficiency and optimize Euclid Ortho-K fits. The MyEuclid portal was released on a limited basis earlier this year, and the platform is now availa
- Opus Genetics Appoints Ben Yerxa, PhD, as Permanent Chief Executive Officerhttps://modernod.com/news/opus-genetics-appoints-ben-yerxa-phd-as-permanent-chief-executive-officer/2480923/Opus Genetics announced the appointment of Ben Yerxa, PhD, as Chief Executive Officer. Dr. Yerxa previously served as acting CEO of Opus, in addition to former roles as CEO of the Foundation Fighting Blindness and the Retinal Degeneration (RD) Fund, the venture arm of th
- Aurion Biotech Appoints Michael Goldstein, MD, as President and Chief Medical Officerhttps://modernod.com/news/aurion-biotech-appoints-dr-michael-goldstein-as-president-and-chief-medical-officer/2480904/Aurion Biotech announced it has appointed Michael Goldstein, MD, as president and chief medical officer. Dr. Goldstein will lead the company’s clinical strategy, development and operations; medical affairs; and manufacturing and quality teams for its first product candidate, a cel
- Eyenovia Announces Planned Chief Executive Officer Transitionhttps://modernod.com/news/eyenovia-announces-planned-chief-executive-officer-transition/2480898/Eyenovia announced that Sean Ianchulev, MD, co-founder, chief medical officer, and chief executive officer, will step down as chief executive officer and transition to the role of non-executive Chairman of the Board. The definitive timeline for the transition will be determin
- Dopavision Appoints Mark S. Wuttke, PhD, as Chief Executive Officerhttps://modernod.com/news/dopavision-appoints-mark-s-wuttke-phd-as-chief-executive-officer/2480881/Dopavision announced that Mark S. Wuttke, PhD, has been appointed as the company´s Chief Executive Officer. He succeeds Dopavision´s co-founder and previous Managing Director Stefan Zundel, who will remain on Dopavision´s advisory board and continue to advise the company.</